Develops tritium-labeled peptides to study how Selank and related peptides are metabolized in living tissue. Using isotope-labeled Selank, tracks all metabolic breakdown products with high sensitivity. Identifies which amino acid sequences are cleaved first and how quickly—providing pharmacokinetic data critical for understanding Selank's duration of action and bioavailability.
Zolotarev, Iu A; Dadaian, A K; Dolotov, O V; Kozik, V S; Kost, N V; Sokolov, O Iu; Dorokhova, E M; Meshavkin, V K; Inozemtseva, L S; Gabaeva, M V; Andreeva, L A; Alfeeva, L Iu; Pavlov, T S; Badmaeva, K E; Badmaeva, S E; Bakaeva, Z V; Kopylova, G N; Samonina, G E; Vas'kovskiĭ, B V; Grivennikov, I A; Zozulia, A A; Miasoedov, N F